Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 24, 2023JAMA NeurologyOpen Access

Isosorbide Mononitrate and Cilostazol Treatment in Patients With Symptomatic Cerebral Small Vessel Disease

View Full Paper
Ask AI
Bookmark
Share

Authors

Joanna M. WardlawJoanna M. WardlawBoston UniversityLWLisa J WoodhouseUniversity of NottinghamIMIris MhlangaUniversity of Nottingham

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wardlaw et al. (2023) studied this question.

synapsesocial.com/papers/6a7d00622c1f7923a7964978https://doi.org/10.1001/jamaneurol.2023.1526
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cilostazol and isosorbide mononitrate for the prevention of progression of cerebral small vessel disease: baseline data and statistical analysis plan for the Lacunar Intervention Trial-2 (LACI-2) (ISRCTN14911850)2022 · 7 citations
  2. 2Cilostazol and isosorbide mononitrate for the prevention of progression of cerebral small vessel disease: Baseline data and statistical analysis plan for the Lacunar Intervention Trial-2 (LACI-2) (ISRCTN14911850)2022 · 2 citations
  3. 3Applications of the Wei-Lachin Multivariate One-Sided Test for Multiple Outcomes on Possibly Different Scales2014 · 41 citations
  4. 4Effect of Addition of Clopidogrel to Aspirin on Mortality2012 · 48 citations
  5. 5Cognitive impairment after lacunar stroke: systematic review and meta-analysis of incidence, prevalence and comparison with other stroke subtypes2013 · 275 citations